Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024;77(3):466-471.
doi: 10.5173/ceju.2024.103.R1. Epub 2024 Oct 28.

Thulium laser en bloc resection is a safe and efficacious alternative to conventional bipolar transurethral resection of bladder tumors

Osama Zaytoun  1 , Neeraja Tillu  1 , Kaushik Kolanukuduru  1 , Arjun Venkatesh  2 , Manish Choudhary  1 , Zachary Dovey  1 , Tommasangelo Petitti  3 , Maida Bada  4 , Maurizio Buscarini  1
Affiliations

Thulium laser en bloc resection is a safe and efficacious alternative to conventional bipolar transurethral resection of bladder tumors

Osama Zaytoun et al. Cent European J Urol. 2024.

Abstract

Introduction: Bipolar transurethral resection of bladder tumors (bTURBT) is the standard of care technique for the management of bladder tumors; however, new techniques such as thulium laser en bloc resection of bladder tumors (TmLRBT) have been introduced as alternatives to bTURBT. In this study, detrusor muscle acquisition, perioperative outcomes and survival outcomes after TmLRBT and bTURBT were prospectively compared in patients with primary bladder tumors (1-5 cm).

Material and methods: This prospective interventional study, conducted over ten years, involved 542 patients under a single surgeon. Inclusion criteria were a single tumor of 1-5 cm. The primary endpoint was the presence or absence of detrusor muscle. Perioperative criteria included operative time, hospital stay length, catheterization duration, bladder perforations, readmissions, and complication incidence. Recurrence-free survival (RFS) and cancer-specific survival (CSS) were analyzed using the Kaplan-Meier method with subgroup comparisons by the log-rank test.

Results: Of 449 patients, 211 underwent TmLRBT and 238 underwent bTURBT. Detrusor muscle was present in 201 (95.2%) TmLRBT patients vs 154 (64.7%) bTURBT patients (p <0.001). Complications were less frequent in the TmLRBT group (p <0.05). Hemoglobin drop (p <0.001), hospital stay (p <0.001), catheterization duration (p <0.001), and operative time (p <0.001) were all significantly lower in the TmLRBT group. Kaplan-Meier analysis showed no significant differences in RFS (p = 0.255) and CSS (p = 0.258) between the groups.

Conclusions: TmLRBT demonstrated significantly better detrusor muscle inclusion and perioperative outcomes compared to bTURBT.

Keywords: TURBT; bipolar resection; bladder cancer; bladder tumor; thulium.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flowchart showing the number of subjects enrolled in the study with the exclusion criteria.
Figure 2
Figure 2
Difference in recurence-free survival between patients undergoing bTURBT vs TmLRBT (p = 0.255). bTURBT – bipolar transurethral resection of bladder tumors; TmLRBT – thulium laser en bloc resection of bladder tumors
Figure 3
Figure 3
Difference in cancer-specific survival between patients undergoing bTURBT vs TmLRBT (p = 0.258). bTURBT – bipolar transurethral resection of bladder tumors; TmLRBT – thulium laser en bloc resection of bladder tumors
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Grasso M. Bladder Cancer: A Major Public Health Issue. Eur Urol Suppl. 2008; 7: 510–515.
    1. Brausi M, Collette L, Kurth K, et al. . Variability in the Recurrence Rate at First Follow-up Cystoscopy after TUR in Stage Ta T1 Transitional Cell Carcinoma of the Bladder: A Combined Analysis of Seven EORTC Studies. Eur Urol. 2002; 41: 523–531. - PubMed
    1. Sylvester RJ. Natural History, Recurrence, and Progression in Superficial Bladder Cancer. The Scientific World J. 2006; 6: 2617–2625. - PMC - PubMed
    1. Kirkali Z, Chan T, Manoharan M, et al. . Bladder cancer: Epidemiology, staging and grading, and diagnosis. Urology. 2005; 66: 4–34. - PubMed
    1. Shoshany O, Mano R, Margel D, Baniel J, Yossepowitch O. Presence of detrusor muscle in bladder tumor specimens – predictors and effect on outcome as a measure of resection quality. Urologic Oncology: Seminars and Original Investigations. 2014; 32: 40.e17–40.e22. - PubMed

LinkOut - more resources